Obesity medicine as a subspecialty and United States certification - A review.

Certification Obesity

Journal

Obesity Pillars (Online)
ISSN: 2667-3681
Titre abrégé: Obes Pillars
Pays: United States
ID NLM: 9918697364706676

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 28 03 2023
revised: 10 04 2023
accepted: 10 04 2023
medline: 22 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Certification of obesity medicine for physicians in the United States occurs mainly via the American Board of Obesity Medicine (ABOM). Obesity medicine is not recognized as a subspecialty by the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA). This review examines the value of specialization, status of current ABOM Diplomates, governing bodies involved in ABMS/AOA Board Certification, and the advantages and disadvantages of an ABMS/AOA recognized obesity medicine subspecialty. Data for this review were derived from PubMed and appliable websites. Content was driven by the expertise, insights, and perspectives of the authors. The existing ABOM obesity medicine certification process has resulted in a dramatic increase in the number of Obesity Medicine Diplomates. If ABMS/AOA were to recognize obesity medicine as a subspecialty under an existing ABMS Member Board, then Obesity Medicine would achieve a status like other ABMS recognized subspecialities. However, the transition of ABOM Diplomates to ABMS recognized subspecialists may affect the kinds and the number of physicians having an acknowledged focus on obesity medicine care. Among transition issues to consider include: (1) How many ABMS Member Boards would oversee Obesity Medicine as a subspecialty and which physicians would be eligible? (2) Would current ABOM Diplomates be required to complete an Obesity Medicine Fellowship? If not, then what would be the process for a current ABOM Diplomate to transition to an ABMS-recognized Obesity Medicine subspecialist (i.e., "grandfathering criteria")? and (3) According to the ABMS, do enough Obesity Medicine Fellowship programs exist to recognize Obesity Medicine as a subspecialty? Decisions regarding a transition to an ABMS recognized Obesity Medicine Subspecialty versus retention of the current ABOM Diplomate Certification should consider which best facilitates medical access and care to patients with obesity, and which best helps obesity medicine clinicians be recognized for their expertise.

Sections du résumé

Background UNASSIGNED
Certification of obesity medicine for physicians in the United States occurs mainly via the American Board of Obesity Medicine (ABOM). Obesity medicine is not recognized as a subspecialty by the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA). This review examines the value of specialization, status of current ABOM Diplomates, governing bodies involved in ABMS/AOA Board Certification, and the advantages and disadvantages of an ABMS/AOA recognized obesity medicine subspecialty.
Methods UNASSIGNED
Data for this review were derived from PubMed and appliable websites. Content was driven by the expertise, insights, and perspectives of the authors.
Results UNASSIGNED
The existing ABOM obesity medicine certification process has resulted in a dramatic increase in the number of Obesity Medicine Diplomates. If ABMS/AOA were to recognize obesity medicine as a subspecialty under an existing ABMS Member Board, then Obesity Medicine would achieve a status like other ABMS recognized subspecialities. However, the transition of ABOM Diplomates to ABMS recognized subspecialists may affect the kinds and the number of physicians having an acknowledged focus on obesity medicine care. Among transition issues to consider include: (1) How many ABMS Member Boards would oversee Obesity Medicine as a subspecialty and which physicians would be eligible? (2) Would current ABOM Diplomates be required to complete an Obesity Medicine Fellowship? If not, then what would be the process for a current ABOM Diplomate to transition to an ABMS-recognized Obesity Medicine subspecialist (i.e., "grandfathering criteria")? and (3) According to the ABMS, do enough Obesity Medicine Fellowship programs exist to recognize Obesity Medicine as a subspecialty?
Conclusions UNASSIGNED
Decisions regarding a transition to an ABMS recognized Obesity Medicine Subspecialty versus retention of the current ABOM Diplomate Certification should consider which best facilitates medical access and care to patients with obesity, and which best helps obesity medicine clinicians be recognized for their expertise.

Identifiants

DOI: 10.1016/j.obpill.2023.100062 PMID: 37990658 PMC: PMC10661990
pubmed: 37990658
doi: 10.1016/j.obpill.2023.100062
pii: S2667-3681(23)00008-6
pmc: PMC10661990
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100062

Informations de copyright

© 2023 The Authors.

Références

Lancet. 2011 Aug 27;378(9793):838-47
pubmed: 21872752
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
BMC Health Serv Res. 2018 Apr 5;18(1):244
pubmed: 29622008
Pediatrics. 2018 Jan;141(1):
pubmed: 29269386
JAMA. 2015 May 12;313(18):1805-6
pubmed: 25965217
Obes Facts. 2022;15(4):560-569
pubmed: 35358970
BMC Fam Pract. 2016 Aug 09;17:108
pubmed: 27506455
BMJ. 2006 Nov 4;333(7575):959-62
pubmed: 17082548
Psychol Bull. 2006 Sep;132(5):667-91
pubmed: 16910747
Ann Intern Med. 1991 Nov 1;115(9):715-9
pubmed: 1929041
Obesity (Silver Spring). 2017 Jun;25(6):982-984
pubmed: 28544791
J Natl Med Assoc. 2021 Oct;113(5):486-492
pubmed: 33875239
Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240
pubmed: 30704950
Health Aff (Millwood). 2017 Oct 1;36(10):1808-1814
pubmed: 28971927
Clin Obes. 2021 Feb;11(1):e12407
pubmed: 33280270
Acad Med. 2016 Nov;91(11):1509-1515
pubmed: 27355778
Acad Pediatr. 2021 Apr;21(3):557-563
pubmed: 33127591
Int J Epidemiol. 2020 Jun 1;49(3):810-823
pubmed: 32016289

Auteurs

Angela Fitch (A)

Diplomate of American Board of Obesity Medicine, Knownwell, 15 Oak St Suite 3, Needham, MA, 02492, USA.

Deborah B Horn (DB)

Diplomate of American Board of Obesity Medicine, UT Center for Obesity Medicine and Metabolic Performance, University of Texas McGovern Medical School, 6348 Sewanee Ave, Houston, TX, 77005, USA.

Christopher D Still (CD)

Diplomate of American Board of Obesity Medicine, Department of Clinical Sciences, Geisinger Commonwealth School of Medicine, Center for Nutrition & Weight Management, Geisinger Obesity Institute, Geisinger Health System, 100 North Academy Avenue, MC 21-11, USA.

Lydia C Alexander (LC)

Diplomate of American Board of Obesity Medicine, Enara Health, 3050 S. Delaware Street, Suite 130, San Mateo, CA, 94403, USA.

Sandra Christensen (S)

Certificate of Advanced Education in Obesity Medicine, Integrative Medical Weight Management, 2611 NE 125th St, Suite 100B, Seattle, WA, 98125, USA.

Nicholas Pennings (N)

Diplomate of American Board of Obesity Medicine, Campbell University School of Osteopathic Medicine, 4350 US Hwy 421 S, Lillington, NC, 27546, USA.

Harold Edward Bays (HE)

Diplomate of American Board of Obesity Medicine, Louisville Metabolic and Atherosclerosis Research Center, University of Louisville School of Medicine, 3288 Illinois Avenue, Louisville, KY, 40213, USA.

Classifications MeSH